Center for Scientific Review; Notice of Closed Meetings, 31029-31030 [2012-12651]
Download as PDF
<![CDATA[
31029
Federal Register / Vol. 77, No. 101 / Thursday, May 24, 2012 / Notices
TABLE 1—ESTIMATE OF ANNUAL BURDEN HOURS
Average time
per response
(minutes/hour)
Annual burden
hours
1
1
1/60
2/60
1,123
810
4,200
1
5/60
350
1,300
1,000
1
4
2/60
1/60
43
67
Demographic questions ...................
7,800
1
2/60
260
...........................................................
........................
........................
........................
2,653
Type of respondents
Number of
respondents
Survey instrument
Frequency of
responses
Telephone Clients
Customer Service .............................
Demographic Questions ...................
67,400
24,300
Smoking Cessation ‘‘Quitline’’ Clients
Reactive Service Clients ...................
Proactive Callback Service Clients ...
Smoking Cessation ‘‘Intake’’ Questions.
Demographic Questions ...................
Follow-Up .........................................
LiveHelp Clients 4
srobinson on DSK4SPTVN1PROD with NOTICES
Total ...........................................
The annual number of responses is
estimated to be 109,000 and the
annualized cost to the respondents is
estimated at $93,185. There are no
Capital Costs, Operating Costs, and/or
Maintenance Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Mary Anne Bright,
Associate Director, Office of Public
Information and Resource Management,
Office of Communications and
Education, National Cancer Institute,
6116 Executive Blvd., Room 3023, MSC
8322, Bethesda, MD 20892–8322 or call
301–594–9048 or email your request,
including your address, to:
brightma@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
VerDate Mar<15>2010
16:31 May 23, 2012
Jkt 226001
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: May 18, 2012.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2012–12654 Filed 5–23–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Gene and Drug Delivery Systems
Study Section.
Date: June 20–21, 2012.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road NW.,
Washington, DC 20008.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Contact Person: Amy L. Rubinstein, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152,
MSC 7844, Bethesda, MD 20892, 301–408–
9754, rubinsteinal@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Bacterial Pathogenesis Study Section.
Date: June 20, 2012.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–402–
4454, kostrikr@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative and Clinical Endocrinology and
Reproduction Study Section.
Date: June 20, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sax Chicago, 333 N. Dearborn,
Chicago, IL 60654.
Contact Person: Dianne Hardy, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6175, MSC 7892, Bethesda, MD
20892, 301–435–1154,
dianne.hardy@nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Urologic and Genitourinary Physiology and
Pathology.
Date: June 20, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Avenue Hotel Chicago, 160 E. Huron
Street, Chicago, IL 60611.
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Center for
E:\FR\FM\24MYN1.SGM
24MYN1
srobinson on DSK4SPTVN1PROD with NOTICES
31030
Federal Register / Vol. 77, No. 101 / Thursday, May 24, 2012 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Vector Biology Study Section.
Date: June 20–21, 2012.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214,
MSC 7808, Bethesda, MD 20892, 301–402–
5671, zhengli@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Prokaryotic Cell and Molecular Biology
Study Section.
Date: June 20–21, 2012.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Michael K Schmidt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214,
MSC 7890, Bethesda, MD 20892, (301) 404–
9958, mschmidt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PA12–017:
Shared Instrumentation: Electron
Microscopes.
Date: June 20, 2012.
Time: 10:00 a.m. to 10:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Wallace Ip, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, 301–435–
1191. ipws@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroimmunology, Multiple Sclerosis,
Alzheimer’s Disease, and Sleep Apnea and
Restless Leg Syndrome.
Date: June 20, 2012.
Time: 11:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
IRG Chief, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Liver Pathobiology, Toxicology,
and Pharmacology.
VerDate Mar<15>2010
16:31 May 23, 2012
Jkt 226001
Date: June 20, 2012.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Peter J. Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 18, 2012
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–12651 Filed 5–23–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Dated: May 18, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–12650 Filed 5–23–12; 8:45 am]
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: June 27–28, 2012.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: June 27, 2012—Drug User Fee
Programs, Generic Cancer Drug Shortages:
Continuing the Dialogue, The Role of the
Cancer Advocacy Community; June 28,
2012—NCI Update.
Place: National Institutes of Health,
Building 31, C Wing, 6th Floor, Conference
Room 10, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Amy Bulman, Acting
Director, Office of Advocacy Relations,
National Cancer Institute, National Institutes
of Health, 31 Center Drive, Building 31,
Room 10A30, Bethesda, MD 20892, 301–496–
9723.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Language and Communication Study
Section.
Date: June 18, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW., Washington, DC 20037.
E:\FR\FM\24MYN1.SGM
24MYN1
]]>Agencies
[Federal Register Volume 77, Number 101 (Thursday, May 24, 2012)]
[Notices]
[Pages 31029-31030]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12651]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Gene and Drug Delivery Systems Study
Section.
Date: June 20-21, 2012.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Marriott Wardman Park Washington DC Hotel, 2660 Woodley
Road NW., Washington, DC 20008.
Contact Person: Amy L. Rubinstein, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5152, MSC 7844, Bethesda, MD
20892, 301-408-9754, rubinsteinal@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Bacterial Pathogenesis Study Section.
Date: June 20, 2012.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115.
Contact Person: Richard G. Kostriken, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 301-402-4454, kostrikr@csr.nih.gov.
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Integrative and
Clinical Endocrinology and Reproduction Study Section.
Date: June 20, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sax Chicago, 333 N. Dearborn, Chicago, IL 60654.
Contact Person: Dianne Hardy, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6175, MSC 7892, Bethesda, MD 20892, 301-435-1154,
dianne.hardy@nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Urologic and Genitourinary Physiology and
Pathology.
Date: June 20, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Avenue Hotel Chicago, 160 E. Huron Street, Chicago, IL
60611.
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Center for
[[Page 31030]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301-435-1501,
morrisr@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Vector Biology Study Section.
Date: June 20-21, 2012.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD
20892, 301-402-5671, zhengli@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Prokaryotic Cell and Molecular Biology Study Section.
Date: June 20-21, 2012.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Nikko San Francisco, 222 Mason Street, San
Francisco, CA 94102.
Contact Person: Michael K Schmidt, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214, MSC 7890, Bethesda, MD
20892, (301) 404-9958, mschmidt@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PA12-017: Shared Instrumentation: Electron Microscopes.
Date: June 20, 2012.
Time: 10:00 a.m. to 10:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wallace Ip, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, 301-435-
1191. ipws@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuroimmunology, Multiple Sclerosis, Alzheimer's Disease, and
Sleep Apnea and Restless Leg Syndrome.
Date: June 20, 2012.
Time: 11:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D., IRG Chief, Center for
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD 20892, (301) 435-1246,
edwardss@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Liver Pathobiology, Toxicology, and
Pharmacology.
Date: June 20, 2012.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Peter J. Perrin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD
20892, (301) 435-0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 18, 2012
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-12651 Filed 5-23-12; 8:45 am]
BILLING CODE 4140-01-P
